BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

  1. Homepage
  2. Medicinal products
  3. Pharmacovigilance
  4. Risk information

Dear Doctor Letter (Rote-Hand-Brief) on the use of intrauterine devices (IUDs): Risk of uterine perforation

2015.07.23

Active substance: levonorgestrel

In view of updated results of the "European Active Surveillance Study for Intrauterine Devices” (EURAS-IUD), the company Jenapharm GmbH & Co. KG is circulating information on the investigation of the use of copper-bearing intrauterine devices (Cu-IUDs) and levonorgestrel-releasing intrauterine systems (LNG-IUS).

Download DHPC/Information letter , Download_VeroeffentlichtAm_EN PDF, 436KB, File is accessible